发明名称 Substituted biphenyl isoxazole sulfonamides
摘要 Compounds of the formula <IMAGE> I inhibit the activity of endothelin. The symbols are defined as follows: R1, R2, R3 and R4 are each directly bonded to a ring carbon and are each independently (a) hydrogen; (b) alkyl, alkenyl, alkynyl, alkoxy, cycloalkyl, cycloalkylalkyl, cycloalkenyl, cycloalkenylalkyl, aryl, aryloxy, aralkyl or aralkoxy, any of which may be substituted with Z1, Z2 and Z3; (c) halo; (d) hydroxyl; (e) cyano; (f) nitro; (g) -C(O)H or -C(O)R5; (h) -CO2H or -CO2R5; (i) -Z4-NR6R7; (j) -Z4-N(R10)-Z5-NR8R9; or (k) R3 and R4 together may also be alkylene or alkenylene, either of which may be substituted with Z1, Z2 and Z3, completing a 4- to 8-membered saturated, unsaturated or aromatic ring together with the carbon atoms to which they are attached; and the remaining symbols are as defined in the specification.
申请公布号 AU2209897(A) 申请公布日期 1997.09.02
申请号 AU19970022098 申请日期 1997.02.20
申请人 BRISTOL-MYERS SQUIBB COMPANY 发明人 NATESAN MURUGESAN;JOEL C. BARRISH;STEVEN H. SPERGEL
分类号 C07D261/16;A61K31/42;A61K31/422;A61K31/427;A61K31/433;A61K31/437;A61K31/4439;A61K31/4709;A61K31/496;A61K31/497;A61K31/501;A61K31/506;A61K31/5377;A61K31/5383;A61P9/02;A61P9/04;A61P9/10;A61P9/12;A61P13/08;A61P13/12;A61P25/06;A61P43/00;C07D231/42;C07D413/12;C07D413/14;C07D417/12;C07D417/14;C07D471/04;C07D498/04;C07D521/00 主分类号 C07D261/16
代理机构 代理人
主权项
地址